Literature DB >> 33932583

Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.

Monique D Appelman1, Jochen M Wettengel2, Ulrike Protzer3, Ronald P J Oude Elferink4, Stan F J van de Graaf5.   

Abstract

Transporters expressed by hepatocytes and enterocytes play a critical role in maintaining the enterohepatic circulation of bile acids. The sodium taurocholate cotransporting polypeptide (NTCP), exclusively expressed at the basolateral side of hepatocytes, mediates the uptake of conjugated bile acids. In conditions where bile flow is impaired (cholestasis), pharmacological inhibition of NTCP-mediated bile acid influx is suggested to reduce hepatocellular damage due to bile acid overload. Furthermore, NTCP has been shown to play an important role in hepatitis B virus (HBV) and hepatitis Delta virus (HDV) infection by functioning as receptor for viral entry into hepatocytes. This review provides a summary of current molecular insight into the regulation of NTCP expression at the plasma membrane, hepatic bile acid transport, and NTCP-mediated viral infection.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ASBT; BSEP; Cholestasis; HBV; HDV

Year:  2021        PMID: 33932583     DOI: 10.1016/j.bbalip.2021.158960

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  8 in total

1.  Structure of the bile acid transporter and HBV receptor NTCP.

Authors:  Jinta Asami; Kanako Terakado Kimura; Yoko Fujita-Fujiharu; Hanako Ishida; Zhikuan Zhang; Yayoi Nomura; Kehong Liu; Tomoko Uemura; Yumi Sato; Masatsugu Ono; Masaki Yamamoto; Takeshi Noda; Hideki Shigematsu; David Drew; So Iwata; Toshiyuki Shimizu; Norimichi Nomura; Umeharu Ohto
Journal:  Nature       Date:  2022-05-17       Impact factor: 49.962

2.  Tyrosine 146 of the Human Na+/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes.

Authors:  Dariusz Zakrzewicz; Regina Leidolf; Sebastian Kunz; Simon Franz Müller; Anita Neubauer; Silke Leiting; Nora Goldmann; Felix Lehmann; Dieter Glebe; Joachim Geyer
Journal:  Viruses       Date:  2022-06-09       Impact factor: 5.818

3.  Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice.

Authors:  Wen-Wen Zhao; Meng Xiao; Xia Wu; Xiu-Wei Li; Xiao-Xi Li; Ting Zhao; Lan Yu; Xiao-Qing Chen
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

4.  Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.

Authors:  Michael Kirstgen; Simon Franz Müller; Kira Alessandra Alicia Theresa Lowjaga; Nora Goldmann; Felix Lehmann; Sami Alakurtti; Jari Yli-Kauhaluoma; Karl-Heinz Baringhaus; Reimar Krieg; Dieter Glebe; Joachim Geyer
Journal:  Viruses       Date:  2021-07-29       Impact factor: 5.048

5.  Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications.

Authors:  Jochen M Wettengel; Bianca Linden; Knud Esser; Michael Laue; Benjamin J Burwitz; Ulrike Protzer
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

6.  Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.

Authors:  Toshitada Takemori; Akiko Sugimoto-Ishige; Hironori Nishitsuji; Yushi Futamura; Michishige Harada; Tomomi Kimura-Someya; Takehisa Matsumoto; Teruki Honma; Miho Tanaka; Masami Yaguchi; Kyoichi Isono; Haruhiko Koseki; Hiroyuki Osada; Daiki Miki; Takashi Saito; Takashi Tanaka; Takehiro Fukami; Toshio Goto; Mikako Shirouzu; Kunitada Shimotohno; Kazuaki Chayama
Journal:  J Virol       Date:  2022-01-05       Impact factor: 5.103

Review 7.  Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment.

Authors:  Yan Li; Jun Zhou; Tianliang Li
Journal:  Front Mol Biosci       Date:  2022-04-12

Review 8.  Multitasking Na+/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery.

Authors:  Dariusz Zakrzewicz; Joachim Geyer
Journal:  Biomedicines       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.